Carbamazepine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00564 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 58 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | trigeminal nerve neoplasm | KG + DL |
| 2 | micturation-induced seizures | KG + DL |
| 3 | audiogenic seizures | KG + DL |
| 4 | thinking seizures | KG + DL |
| 5 | orgasm-induced seizures | KG + DL |
| 6 | startle epilepsy | KG + DL |
| 7 | eating seizures | KG + DL |
| 8 | reading seizures | KG + DL |
| 9 | beta-ketothiolase deficiency | KG + DL |
| 10 | Rett syndrome, congenital variant | KG + DL |
| 11 | 14q12 microdeletion syndrome | KG + DL |
| 12 | status epilepticus | KG + DL |
| 13 | adolescent/adult onset autosomal dominant epilepsy with auditory features | KG + DL |
| 14 | facial neuralgia | KG + DL |
| 15 | guanidinoacetate methyltransferase deficiency | KG + DL |
| 16 | combined hyperactive dysfunction syndrome of the cranial nerves | KG + DL |
| 17 | glossopharyngeal nerve neoplasm | KG + DL |
| 18 | vagus nerve disease | KG + DL |
| 19 | glossopharyngeal nerve paralysis | KG + DL |
| 20 | trichotillomania | KG + DL |
| 21 | myoclonic-atonic epilepsy | KG + DL |
| 22 | Tourette syndrome | KG + DL |
| 23 | febrile infection-related epilepsy syndrome | KG + DL |
| 24 | atypical childhood epilepsy with centrotemporal spikes | KG + DL |
| 25 | photosensitive occipital lobe epilepsy | KG + DL |
| 26 | cryptogenic late-onset epileptic spasms | KG + DL |
| 27 | perioral myoclonia with absences | KG + DL |
| 28 | restless legs syndrome | KG + DL |
| 29 | electroclinical syndrome | KG + DL |
| 30 | nicotine dependence | KG + DL |
| 31 | methemoglobinemia, alpha type | KG + DL |
| 32 | idiopathic neonatal atrial flutter | KG + DL |
| 33 | attention deficit-hyperactivity disorder | KG + DL |
| 34 | early onset absence epilepsy | KG + DL |
| 35 | methemoglobin reductase deficiency | KG + DL |
| 36 | myofascial pain syndrome | KG + DL |
| 37 | asperger syndrome, susceptibility to | KG + DL |
| 38 | gaze palsy, familial horizontal, with progressive scoliosis | KG + DL |
| 39 | multifocal atrial tachycardia (disease) | KG + DL |
| 40 | childhood onset epileptic encephalopathy | KG + DL |
| 41 | autism susceptibility 1 | KG + DL |
| 42 | faciodigitogenital syndrome | KG + DL |
| 43 | methemoglobinemia | KG + DL |
| 44 | autism spectrum disorder | KG + DL |
| 45 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 46 | EAST syndrome | KG + DL |
| 47 | amelocerebrohypohidrotic syndrome | KG + DL |
| 48 | early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation | KG + DL |
| 49 | methemoglobinemia due to deficiency of methemoglobin reductase | KG + DL |
| 50 | specific developmental disorder | KG + DL |
(Showing top 50 of 58 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.